Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...

A fresh take on gene-editing, centered on engineered recombinases, emerges as Brink Therapeutics, a Paris-based biotech startup, secures €3.5 million ($4 million) in seed funding with Kuma Partners ...